Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Reiko, Yoshie"'
Autor:
Chihiro Udagawa, Sherwin Kuah, Tatsunori Shimoi, Ken Kato, Teruhiko Yoshida, Mari Hara Nakano, Arata Shimo, Yasuyuki Kojima, Reiko Yoshie, Koichiro Tsugawa, Taisei Mushiroda, Ern Yu Tan, Hitoshi Zembutsu
Publikováno v:
Biologicalpharmaceutical bulletin. 45(8)
Trastuzumab (herceptin) is an effective drug for human epidermal growth factor receptor type 2 (HER2)-positive cancer. However, cardiotoxicity remains a serious complication. In our previous genome-wide association study (GWAS), we identified potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73a7b1d126ac51447d5747269b9e3120
https://pubmed.ncbi.nlm.nih.gov/35908902
https://pubmed.ncbi.nlm.nih.gov/35908902
Autor:
Arata Shimo, Ai Motoyoshi, Yoshihide Kanemaki, Hidefumi Mimura, Reiko Yoshie, Yasuyuki Kojima, Koichiro Tsugawa, Hisanori Kawamoto, Ei Haku, Akihiko Suto, Mizuho Tazo, Yukari Yabuki, Mari Hara Nakano, Mamoru Fukuda, Ichiro Maeda, Mariko Takishita, Ayaka Shimo, Ryoko Oi, Takako Kuroda, Tsuguo Iwatani, Tomoko Tsuruga
Publikováno v:
Journal of Cancer Therapy. 12:563-576
Objective: This study aimed to evaluate the feasibility, safety, and cosmetic outcomes of percutaneous cryoablation (PCA) of breast intraductal carcinoma (IDC) lesions, as well as post-cryoablation magnetic resonance imaging (MRI) as a follow-up tool
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8b25512a40ca4ce1ff1ffbf8299d799
https://doi.org/10.4236/jct.2021.1210047
https://doi.org/10.4236/jct.2021.1210047
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 81:1482-1488
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4497d6bbdbb1fd6c684bec75c4067454
https://doi.org/10.3919/jjsa.81.1482
https://doi.org/10.3919/jjsa.81.1482
Autor:
Ei, Haku, Yasuyuki, Kojima, Kaori, Sakamaki, Mina, Kitajima, Mariko, Takishita, Nao, Sakamoto, Mizuho, Tazou, Mari, Nakano, Takako, Kuroda, Reiko, Yoshie, Tomoko, Tsuruga, Ayaka, Shimo, Arata, Shimo, Ai, Motoyoshi, Hisanori, Kawamoto, Mamoru, Fukuda, Koichiro, Tsugawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 47(10)
We investigated factors related to the recurrence and prognosis of patients with triple-negative breast cancer (TNBC)after neoadjuvant chemotherapy(NAC). Of the 545 patients who underwent surgery after NAC between January 2013 and December 2016, 131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c92945cee9f637a061eba3284abd95b7
https://pubmed.ncbi.nlm.nih.gov/33130739
https://pubmed.ncbi.nlm.nih.gov/33130739
Autor:
Tatsunori Shimoi, Reiko Yoshie, Tokiwa Motonari, Mikiko Unesoko, Taisei Mushiroda, Kenji Tamura, Hisamitsu Zaha, Hiromi Sakamoto, Koichiro Tsugawa, Masayuki Yoshida, Teruhiko Yoshida, Yasuyuki Kojima, Ken Kato, Mari Hara Nakano, Hitoshi Zembutsu, Norie Abe, Arata Shimo, Chihiro Udagawa
Publikováno v:
Biologicalpharmaceutical bulletin. 42(12)
Trastuzumab has been administered to patients with human epidermal growth factor receptor 2 (HER2)-positive cancer, however, the cardiotoxicity is identified as one of the life-threatening toxicities. Clinically useful biomarker for trastuzumab-induc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::539fa97cc718beb710995b57bcae3150
https://pubmed.ncbi.nlm.nih.gov/31597885
https://pubmed.ncbi.nlm.nih.gov/31597885
Autor:
Koichiro Tsugawa, Ryosuke Hayami, Tomoko Uejima, Yoshihide Kanemaki, Reiko Yoshie, Mamoru Fukuda, Seiko Tsuchiya, Yasuyuki Kojima, Yukari Yabuki, Toru Nishikawa, Ichiro Maeda, Arata Shimo, Ayaka Shimo, Hisanori Kawamoto, Akihiko Sudo, Kyoko Tsuchiya
Publikováno v:
Breast Cancer. 23:851-860
Nipple-sparing mastectomy (NSM) is an advantageous treatment option, providing a complete cure and good cosmetic results. We tested whether NSM is a surgically and oncologically safe technique. We evaluated the oncological outcome of 425 breasts in 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f7c1f8b30da1874df70dc91d625a8f7
https://doi.org/10.1007/s12282-015-0651-6
https://doi.org/10.1007/s12282-015-0651-6
Autor:
Chihiro Udagawa, Mari Hara, Arata Shimo, Yasuyuki Kojima, Reiko Yoshie, Hisamitsu Zaha, Norie Abe, Tokiwa Motonari, Mikiko Unesoko, Kenji Tamura, Tatsunori Shimoi, Masayuki Yoshida, Teruhiko Yoshida, Hiroshi Okamura, Taisei Mushiroda, Koichiro Tsugawa, Hitoshi Zembutsu
Publikováno v:
Cancer Research. 79:2951-2951
Purpose: Trastuzumab has been administered to HER2-positive breast or gastric cancer patients as an effective treatment, however, the cardiotoxicity is identified as one of the life-threatening side effects. To identify a novel genetic marker(s) dete
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb9d391e5156a67dc2fa4d734047b280
https://doi.org/10.1158/1538-7445.am2019-2951
https://doi.org/10.1158/1538-7445.am2019-2951